1 / 20

Smallpox Vaccinee Evaluation and Follow-Up

Smallpox Vaccinee Evaluation and Follow-Up. WVDHHR/BPH US Department of Health and Human Services Centers for Disease Control and Prevention December 2002 / January 2003. Smallpox Vaccinee Evaluation and Follow-Up. Learning Objectives:

jcastellanos
Télécharger la présentation

Smallpox Vaccinee Evaluation and Follow-Up

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Smallpox Vaccinee Evaluation and Follow-Up WVDHHR/BPH US Department of Health and Human Services Centers for Disease Control and Prevention December 2002 / January 2003

  2. Smallpox Vaccinee Evaluation and Follow-Up • Learning Objectives: • Describe the “take” that can be expected after vaccination • Describe the care of the vaccination site • Describe the management of vaccinees after vaccination • Describe the system for vaccinee follow-up in West Virginia

  3. Normal Response to Vaccination – “Take” • First (primary) Vaccination • Vesicular or pustular lesion • Area of definite palpable induration surrounding a center crust or ulcer • Revaccination • Less pronounced and more rapid progression • Pustular lesion or induration surrounding a central crust or ulcer • Take MUST be documented

  4. Normal Variants • Local satellite lesions • Lymphangitis • Local edema • Viral cellulitis • Swelling and tenderness of axillary lymph nodes, usually during 2nd week • Fever and malaise common

  5. Satellite Lesion

  6. Lymphangitis

  7. Edema

  8. Viral Cellulitis

  9. Equivocal Reaction • All responses other than major reaction or ‘take’ • Caused by partial immunity, insufficiently potent vaccine, vaccination technique failure • Vaccination should be repeated ASAP, if possible

  10. Vaccination Site Care • Virus can be recovered at site from time of papule until scab separates • Site should be kept dry and covered • Normal bathing can occur if covered by a waterproof bandage • Healthcare workers should keep site covered • Use gauze or similar absorbent material

  11. Vaccination Site Care • Cover this with semi-permeable dressing • Hand hygiene immediately after handling dressing or contact with site CRITICAL to preventing spread • Other infection control precautions to prevent contact with site • Clothing over site

  12. Vaccination Site Care • Do NOT use semi-permeable dressing alone; could cause: • maceration of vaccination site • prolonged irritation and itching • increases touching/scratching, thereby contaminating hands • Designate staff to assess dressings daily

  13. Administrative Leave • Do not need to place healthcare workers on leave, unless: • physically unable to work due to systemic signs and symptoms • extensive skin lesions or vaccination site that cannot be covered • healthcare workers do not adhere to infection control precautions and recommendations

  14. Follow-up in West Virginia • Vaccinee take-home information: • List the number of the local vaccine safety monitor • Vaccine safety monitor • Monitor the vaccination site daily • Refer to Hospital Assigned Physicians for serious adverse events / questions • Support for HAPS / Vax Safety Monitor • IDEP: 800-423-1271 • CDC: contractor 800-###-#TBA

  15. Twenty-one Day Diary • Surveillance for mild adverse events • Record PVN for vaccinee on the form • Give to vaccinee at clinic • Educate them to record symptoms daily until day 21 • Collect when the scab falls off. • Send to: IDEP • ATTN: Neely Kaydos-Daniels, PhD

  16. Telephone Survey • Patient Medical History Form has check-off: • ‘Will you participate in a survey?’ • If checked ‘yes:’ notify Neely Kaydos-Daniels, PhD: • Photocopy all forms immediately after vaccination clinic, OR • List name, phone, PVN AND • Fax: 304-558-6335, OR • Mail: Room 125, 350 Capitol St / Charleston, WV 25301

  17. Severe Vaccine Adverse Events • If VIG / Cidofovir is needed • Contact IDEP to initiate request • IDEP / physician will contact CDC • IDEP will work with physician to assure reporting • Reporting • Urgent • IDEP will assist with filing the report

  18. Before you start, you must have: • Vaccine Safety Monitor • Site care education plan • Follow up plan • Hospital Assigned Physicians: • Infectious disease • Allergy/immunology • Neurology • Dermatology • Ophthalmology • Primary care

  19. For More Information • Coming soon: • CDC satellite training • MMWR • IDEP conference calls • IDEP: 800-423-1271 • CDC Smallpox website www.cdc.gov/smallpox • National Immunization Program website www.cdc.gov/nip

More Related